TD

Tirunelveli Padmanabhan Devarajan - Profile

Tirunelveli Padmanabhan Devarajan, Nominee Director and Director, with 22 companies.

About Tirunelveli Padmanabhan Devarajan

Tirunelveli Padmanabhan Devarajan has 14 years in corporate governance. Holds Nominee Director and Director roles. Currently with 7 companies, including Malladi Drugs And Pharmaceuticals Limited and Aizant Drug Research Solutions Private Limited. Formerly with 15 companies, such as Sreyas Holistic Remedies Private Limited and Stericon Pharma Private Limited. Engaged in General Business, Technology and more.

Current Companies 7
Past Companies 15
Total Affiliations 22
Oldest Company Age 45
Companies Associated with Tirunelveli Padmanabhan Devarajan
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Tirunelveli Padmanabhan Devarajan?

Tirunelveli Padmanabhan Devarajan has 14 years in corporate governance. Holds Nominee Director and Director roles. Currently with 7 companies, including Malladi Drugs And Pharmaceuticals Limited and Aizant Drug Research Solutions Private Limited. Formerly with 15 companies, such as Sreyas Holistic Remedies Private Limited and Stericon Pharma Private Limited. Engaged in General Business, Technology and more.

What is Tirunelveli Padmanabhan Devarajan's role in current companies?

Tirunelveli Padmanabhan Devarajan is associated with 7 companies as Nominee Director and Director.

What industries does Tirunelveli Padmanabhan Devarajan specialize in?

Tirunelveli Padmanabhan Devarajan has expertise in General Business, Technology and other sectors.

How many years of experience does Tirunelveli Padmanabhan Devarajan have?

Tirunelveli Padmanabhan Devarajan has 14 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available